Cargando…
Rationally designed ruthenium complexes for 1- and 2-photon photodynamic therapy
The use of photodynamic therapy (PDT) against cancer has received increasing attention over recent years. However, the application of the currently approved photosensitizers (PSs) is limited by their poor aqueous solubility, aggregation, photobleaching and slow clearance from the body. To overcome t...
Autores principales: | Karges, Johannes, Kuang, Shi, Maschietto, Federica, Blacque, Olivier, Ciofini, Ilaria, Chao, Hui, Gasser, Gilles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320011/ https://www.ncbi.nlm.nih.gov/pubmed/32591538 http://dx.doi.org/10.1038/s41467-020-16993-0 |
Ejemplares similares
-
A ruthenium–oligonucleotide bioconjugated photosensitizing aptamer for cancer cell specific photodynamic therapy
por: McKenzie, Luke K., et al.
Publicado: (2021) -
A mitochondria-localized iridium(iii) photosensitizer for two-photon photodynamic immunotherapy against melanoma
por: Wang, Lili, et al.
Publicado: (2023) -
Ruthenium-initiated polymerization of lactide: a route to remarkable cellular uptake for photodynamic therapy of cancer
por: Soliman, Nancy, et al.
Publicado: (2020) -
Rationally Designed Ruthenium Complexes for Breast Cancer Therapy
por: Golbaghi, Golara, et al.
Publicado: (2020) -
Synthesis and charge transfer characteristics of a ruthenium–acetylide complex
por: Kuhrt, Robert, et al.
Publicado: (2020)